LP
WGSWW

LMR Partners’s GeneDx Holdings Warrant WGSWW Stock Holding History

LMR Partners’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,532,805
Closed -$115K – 1641
2024
Q3 		$115K Buy
+1,532,805
New +$53K ﹤0.01% 1036

Other funds holding WGSWW

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

LMR Partners's WGSWW Position: Q2 2026 in Review

LMR Partners held its GeneDx Holdings Warrant (WGSWW) position steady in Q2 2026 at 2,135,439 shares worth $8.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

LMR Partners first reported a position in WGSWW in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.14M in Q1 2022. 14 funds tracked by Wall St. Rank hold WGSWW as of Q2 2026.

  • LMR Partners held 2,135,439 shares of GeneDx Holdings Warrant worth $8.54K as of Q2 2026.
  • LMR Partners left its GeneDx Holdings Warrant share count unchanged in Q2 2026.
  • GeneDx Holdings Warrant made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1447 holding.
  • LMR Partners first reported a position in GeneDx Holdings Warrant in Q2 2021 and has held it in 20 quarters since.
  • LMR Partners's GeneDx Holdings Warrant position peaked at $5.14M in Q1 2022.
  • 14 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.